Patent term adjustment (PTA) adds days to the term of a US patent to make up for delay by the United States Patent and Trademark Office (USPTO) during examination. It is the sum of three kinds of Office delay, less the days lost to the applicant’s own delay and any days counted twice. A patent term adjustment review checks that figure against the file history.
What is patent term adjustment?
Patent term adjustment is a statutory extension of a US utility or plant patent under 35 U.S.C. 154(b). It is added to the normal expiry date, 20 years from the earliest non-provisional US filing date.
The three types of USPTO delay in a patent term adjustment
| Type | Trigger | Days counted |
|---|---|---|
| A delay | The Office misses a deadline: first action by 14 months; response to a reply or appeal within 4 months; grant within 4 months of the issue fee | From the day after each deadline until the Office acts |
| B delay | No grant within 3 years of filing | From the day after the 3-year date until grant, less excluded time |
| C delay | Interference or derivation, a secrecy order or a successful appeal | The length of the proceeding or appeal |
B delay excludes the time from filing a request for continued examination (RCE) to the notice of allowance, and time on appeal.
Applicant delay: how the adjustment is reduced
Applicant delay reduces the adjustment, mainly under the 3-month rule. Every day beyond 3 months taken to reply to a rejection, objection or other request is deducted, whatever reply period the action set (37 CFR 1.704). Other reductions include:
- a supplemental reply that the examiner did not ask for;
- an amendment, RCE or other paper filed after the notice of allowance;
- an appeal brief filed more than 3 months after the notice of appeal;
- an application not ready for examination within 8 months of filing.
A late information disclosure statement (IDS) escapes several of these reductions if a PTO/SB/133 statement confirms the citing communication reached those with a duty of disclosure no more than 30 days earlier. That period cannot be extended, so IDS preparation affects term as well as disclosure, as the guide to IDS rules and fees explains.
Overlap and the final PTA calculation
A and B delay can fall on the same days, which the statute counts once. Overlap arises where A days coincide with counted B days, after the 3-year date and outside RCE or appeal time.
PTA = A + B + C − overlapping days − applicant delay
Worked example 1: A delay with a reduction
The two examples below are invented illustrations and do not describe a real project or patent. For an application filed on 1 March 2021, the first action is due by 1 May 2022 but mailed on 15 July 2022, giving 75 days of A delay. The applicant replies on 15 November 2022, 31 days after the 3-month date. Every later step is on time and there is no B delay. PTA is 75 − 31 = 44 days, so expiry moves from 1 March 2041 to 14 April 2041.
Worked example 2: B delay and overlapping days
A second application is filed on 3 February 2020 and granted on 13 June 2023, with every reply filed within 3 months. The counts below give PTA of 205 + 130 − 35 = 300 days, so the patent expires on 29 November 2040.
| Period | Dates counted | Days |
|---|---|---|
| A: first action late | 4 April–3 June 2021 | 61 |
| A: reply answered late | 2 January–20 April 2022 | 109 |
| A: grant late after the issue fee | 10 May–13 June 2023 | 35 |
| B: no grant within 3 years | 4 February–13 June 2023 | 130 |
| Overlap | 10 May–13 June 2023 | −35 |
Checking and correcting a patent term adjustment
A patent term adjustment service rebuilds the count from the file wrapper. A wrong figure is corrected by:
- reinstatement of term lost under the 3-month rule, requested before grant with a showing of due care, fee USD 452;
- reconsideration within 2 months of grant, extendable under 37 CFR 1.136(a), fee USD 226;
- a civil action in the Eastern District of Virginia within 180 days of the reconsideration decision.
Both fees are the same for every entity size on the USPTO fee schedule, checked in November 2026, which the post on USPTO fee changes summarises.
PTA and double patenting
In In re Cellect (2023), the Federal Circuit assessed obviousness-type double patenting against expiry dates that include PTA. Allergan v. MSN (2024) distinguished it for a first-filed, first-issued patent with a common priority date, so patent term adjustment across a family needs an attorney’s review.
To have the PTA on a grant rebuilt from the full file history inside the 2-month window, contact Synoptic IP through our patent term adjustment page or the contact page.
This guide is general information and is not legal advice.
Frequently Asked Questions
How is patent term adjustment calculated?
PTA equals A delay plus B delay plus C delay, minus overlapping days and applicant delay. Each period is counted in days from the file history, and the result is added to the 20-year expiry date, subject to any terminal disclaimer.
What is the deadline to challenge a PTA determination?
A request for reconsideration is due within 2 months of grant, extendable under 37 CFR 1.136(a), with a fee of USD 226 (November 2026). A civil action in the Eastern District of Virginia must follow within 180 days of the decision on reconsideration.
Does an extension of time reduce patent term adjustment?
Yes, every day beyond 3 months taken to reply to a rejection, objection or other request is deducted. This applies even when the reply is timely because an extension fee was paid, and whatever reply period the Office action set.
Do design patents get patent term adjustment?
No, the PTA rules in 37 CFR 1.702–1.705 exclude design applications. A US design patent filed on or after 13 May 2015 has a fixed term of 15 years from the date of grant, with no adjustment for delay inside the Office.
What is the difference between PTA and PTE?
PTA compensates for delay inside the USPTO and is determined by the Office without a request. Patent term extension (PTE) under 35 U.S.C. 156 restores term lost while a product such as a drug awaited regulatory approval, and needs a separate application.